abstract |
A microcapsule comprising a core component, comprising at least 5% by weight of a mammalian rapamycin blank inhibitor (mTOR), which is rapamycin, wherein said core component is microencapsulated and enclosed in a coating that includes a copolymer. of methyl methacrylate and methacrylic acid. |